Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Rational design of immunological programs for functional regenerative niches.

Zhuang Z., Wang P., Liu Y., Song L., Zhang X., Ouyang H.

Narrative Review on Immune Modulation, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Mater Today Bio (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42518696
DOI
10.1016/j.mtbio.2026.103451

Abstract (original English)

The immune system is a master conductor of tissue repair, yet its therapeutic potential remains underexploited. Moving beyond descriptive biology, we propose 'immunoprogramming' as an active design paradigm that synergistically integrates stem cells and biomaterials to steer host immunity toward pro-regenerative outcomes. Here, we decode the source-specific immunomodulatory signatures of stem cells-from bone marrow and adipose tissue to dental and iPSC-derived populations-and establish how the biochemical and biophysical language of engineered biomaterials can directly command innate and adaptive immune cell fate. Crucially, we emphasize that within integrated cell-scaffold constructs, a bidirectional crosstalk emerges: the biomaterial primes the stem cell, which in turn execute enhanced context-specific immunomodulation. To translate this synergy into a design discipline, we introduce the Synergistic Immuno-Instructional System (SIIS) framework, which modularizes Cell-Source-Specific Immuno-Modules (CSIMs), Biomaterial-Based Immuno-Code (BIC), and Tissue-Specific Immuno-Niche (TSIN). Finally, we discuss translational challenges and advocate for next generation 'immuno-informed' therapeutics that evolve from passive replacement to active immune niche engineering, charting a course for intelligent regenerative medicine.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research